Consistent with this result, analysis of the mRNA-sequencing data from the TCGA breast cancer cohort revealed significant increases in the mRNA expression of over half a dozen UPR signaling genes in samples with higher (> median) than those with lower VIRMA levels (< median) (Fig. 6F). This evidence concerns the gene VIRMA and breast carcinoma.